ALLISON WINN: Open Payments
NPI 1063571354 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,212 in 76 payments from 18 companies in 2025. Trend: 2023 $3,173 · 2024 $3,324 · 2025 $2,212
Food & beverage: $2,212
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $763 |
| AstraZeneca Pharmaceuticals LP | 11 | $212 |
| PFIZER INC. | 12 | $206 |
| Janssen Pharmaceuticals, Inc | 3 | $191 |
| Mallinckrodt Hospital Products Inc. | 1 | $150 |
| GlaxoSmithKline, LLC. | 3 | $149 |
| SANOFI-AVENTIS U.S. LLC | 4 | $84 |
| ABBVIE INC. | 5 | $83 |
| Esperion Therapeutics, Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
Products named: Wegovy, Ozempic, SPRAVATO, FARXIGA, TERLIVAZ, AREXVY, TZIELD, ELIQUIS.
Industry payments across GA — which companies pay providers there.
